Pharmaceutical manufacturing


GSTT Pharmaceuticals - The Pharmacy Manufacturing Unit at Guy's and St Thomas's Hospital is a long established manufacturer of unlicensed medicines, these are produced under a manufacturer's "Specials" licence granted by the Medicines and Healthcare Products Regulatory Agency (MHRA). The unit is based at Guy's Hospital and is part of Guy's and St Thomas' NHS Foundation Trust.

The Unit is amongst the larger NHS manufacturing units in the country and has a long standing history of working with leading clinicians to produce a wide range of non-sterile, sterile and aseptic products and offers over 200 product lines. These medications are required by clinicians for the treatment of their patients but have no licensed alternative available. The team use their extensive knowledge and expertise to develop and manufacture products to meet these clinical needs. A wide range of products within the unit are batch manufactured to continually meet patient clinical needs, additionally some specialised small volume medications are produced to meet the requirements for single named patients.

The department has a record of both innovation and implementation of best practice and is committed to providing the highest quality products, with fast turnarounds, for the best price possible.

The unit has a distinctive range of capabilities, these include:Product List

The team have extensive knowledge and experience in pharmaceutical manufacturing, formulation and testing and would be happy to discuss any requirements that you may have for existing or new products. Please get in touch via phone or email.

To find out more about the units unique capabilities, see below:


Learn more about the extensive range of over 200 products available through the unit.


Pharma Manufacturing

Find out more about our robust approach to quality assurance and quality control

Clinical Trials

Clinical trails

Partner with us for all of your clinical trial product requirements.

Contact Us

Contact us to discuss your specials and clinical trial requirements